Curaleaf Holdings (CURLF) Return on Sales (2019 - 2026)
Curaleaf Holdings (CURLF) recorded quarterly Return on Sales of 0.0% in Q1 2026, up 100.0% quarter-over-quarter from 248.48% in Q4 2025, and little changed on a YoY basis from 0.0% in Q1 2025.
Curaleaf Holdings (CURLF) Return on Sales (2019 - 2026) Analysis & Trends
Curaleaf Holdings' Return on Sales history runs 8 years deep, the most recent figure standing at 0.0% for Q1 2026.
- In Q1 2026, Return on Sales changed 0.0% year-over-year to 0.0%; the TTM figure through Mar 2026 stood at 0.17% (down 17.0% YoY), while the FY2025 annual figure was 0.0%, changed 0.0% from the prior year.
- Return on Sales was 0.0% for Q1 2026 at Curaleaf Holdings, up from 248.48% in the prior quarter.
- In the past five years, Return on Sales ranged from a high of 0.0% in Q1 2022 to a low of 248.48% in Q4 2025.
- Historically, Return on Sales has averaged 35.97% across 5 years, with a median of 0.0% in 2025.
- The sharpest annual moves came in 2024 and 2025: Return on Sales jumped 23156 bps in 2024, then slumped 24848 bps in 2025.
- A 5-year view of Return on Sales shows it stood at 0.0% in 2022, then sank by 9418984 bps to 231.56% in 2023, then surged by 100 bps to 0.0% in 2024, then tumbled by 70876058 bps to 248.48% in 2025, then surged by 100 bps to 0.0% in 2026.
- The last three Return on Sales figures came in at 0.0% (Q1 2026), 248.48% (Q4 2025), and 0.0% (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 0.00% |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 0.00% |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 0.00% |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | 0.00% |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 0.00% |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 0.00% |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | -0.02% |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 0.00% |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | 0.00% |
| 10 | Curaleaf Holdings | - | - | 157.29 Mn | 0.00% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.00% |
| Dec 31, 2025 | -248.48% |
| Sep 30, 2025 | 0.00% |
| Jun 30, 2025 | -95.51% |
| Mar 31, 2025 | 0.00% |
| Dec 31, 2024 | 0.00% |
| Sep 30, 2024 | 0.00% |
| Jun 30, 2024 | 0.00% |
| Mar 31, 2024 | 0.00% |
| Dec 31, 2023 | -231.56% |
| Sep 30, 2023 | 0.00% |
| Jun 30, 2023 | 0.00% |
| Dec 31, 2022 | 0.00% |
| Sep 30, 2022 | 0.00% |
| Jun 30, 2022 | 0.00% |
| Mar 31, 2022 | 0.00% |
| Dec 31, 2021 | 0.00% |
| Sep 30, 2021 | 0.00% |
| Jun 30, 2021 | 0.00% |
| Mar 31, 2021 | 0.00% |